Surginex
PrivateLast Round
Series B
Mar 28, 2024
Total Funding Raised
$9.69M
Company Overview
Surginex is a South Korean biotechnology company founded in 2020 that operates as a drug discovery and development firm. The company has developed 'Odysseus', an AI-based drug discovery platform, and specializes in next-generation Lipid Nanoparticle (LNP) technology for targeted drug delivery. This LNP technology is designed to deliver various genetic payloads like siRNAs, mRNAs, and gene editors to specific organs, enhancing therapeutic accuracy and safety. Surginex aims to provide a one-stop solution from platform development to molecular biology, animal experiments, and clinical trials. The company has raised approximately $9.8 million in venture funding and is actively seeking partnerships for collaboration and licensing to advance its drug delivery technologies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Surginex Comps
Public and private peers based on sector, stage, and business model.
Surginex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 28, 2024 | ||||
| Series A | Nov 11, 2021 |
Surginex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hana Ventures | Series B |
| POSCO Capital | Series B |
| K-Net Investment Partners | Series A |
| Kiwoom Investment | Series B |
| LSK Investment | Series B |
| POSCO Technology Investment | Series B |
| Laguna Investment | Series B, Series A |
Surginex Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Surginex's valuation, stock price, and market status.
